10.12.2019 • NewsDede WillamsDuPontIFF

IFF and Kerry in Slugfest over DuPont’s Nutrition Unit?

IFF and Kerry in Slugfest over DuPont’s Nutrition Unit?
IFF and Kerry in Slugfest over DuPont’s Nutrition Unit?

International Flavors & Fragrances (IFF) is reportedly battling it out with Ireland's Kerry Group to acquire DuPont’s nutrition unit planned to be spun off and sold, possibly in a Reverse Morris Trust, essentially a tax-free merger with another company.

According to the Bloomberg news agency, the two companies are in a bidding war, a situation that has fueled a surge in DuPont’s stock price.

Kerry has long been considered the front runner (DSM of the Netherlands also has been mentioned as a potential bidder) for the business now estimated to be worth as much as $25 billion.  Bloomberg said IFF’S entry presents a challenge for the Irish dairy goods specialist, which has hopes of expanding into the food ingredients sector.

As part of a Reverse Morris Trust, DuPont would combine its nutrition unit with the bidder’s assets to form a new company, which in turn would be spun off to existing DuPont investors and shareholders.

Analysts suggest that the market will have to brace itself for a protracted bidding war. Citing people with knowledge of the discussion, Bloomberg said that while a winning bidder could emerge by the end of the year a Reverse Morris Trust procedure could take more than a year to complete.

The relevant activities with more than 10,000 employees focus on products ranging from sweeteners and emulsifiers to dairy cultures and dietary fibers, with particular strength in areas such as plant-based meats and probiotics.

With nutrition stripped out, the Wilmington, Delaware-based group’s portfolio would be left with materials for industries such as transportation, electronics and construction.


 

Whitepaper

Cannabis Extraction — Temperature Control Systems in Action

Cannabis Extraction — Temperature Control Systems in Action

Cannabis is a crop that has been cultivated for thousands of years and contains many pharmacologically active substances.

Artificial Intelligence

Pierre Racz: "Real Artificial Intelligence Does Not Exist"
part one of a three-part interview series

Pierre Racz: "Real Artificial Intelligence Does Not Exist"

In part one Pierre Racz, President of Genetec, is addressing why IP network video systems were the game changer in the industry and why he does not like the term AI.

most read

Photo
15.01.2025 • News

Global Outlook on Bio-based Polymers

It is important to examine the current state of bio-based polymers. This includes the rapidly growing production capacity, significant investments currently underway in China, Europe, and the Middle East, and the new political conditions in Europe that are driving demand for biodegradable polymers.

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.